{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:26:53Z","timestamp":1762100813818,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ijcard.2008.01.038","type":"journal-article","created":{"date-parts":[[2008,5,24]],"date-time":"2008-05-24T05:04:13Z","timestamp":1211605453000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma indices of endothelial and platelet activation in Rheumatoid Disease: Relationship to cardiovascular co-morbidity"],"prefix":"10.1016","volume":"134","author":[{"given":"Gurbir S.","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Sosin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeetesh V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl A.","family":"Grindulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazal H.","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell C.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2008.01.038_bib1","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.01.038_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2004.12.064","article-title":"Rheumatoid Disease and ischaemic heart disease: insights from pathophysiology and vascular biology","volume":"105","author":"Bhatia","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/07853890310021607","article-title":"Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new \u2018vascular triad\u2019","volume":"36","author":"Lip","year":"2004","journal-title":"Ann Med"},{"key":"10.1016\/j.ijcard.2008.01.038_bib4","first-page":"71","article-title":"Haemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8\u00a0year follow up study","volume":"27","author":"Wallberg-Jonsson","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joints counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2008.01.038_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.HYP.0000022061.12297.2E","article-title":"Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)","volume":"40","author":"Spencer","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2008.01.038_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlon","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2008.01.038_bib8","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.ATV.13.12.1829","article-title":"Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"13","author":"Folsom","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ijcard.2008.01.038_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9149(99)80129-5","article-title":"Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms","volume":"76","author":"Lip","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib10","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.103.13.1746","article-title":"Abnormalities of hemorrheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy","volume":"103","author":"Gibbs","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.01.038_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/ard.52.9.643","article-title":"Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis","volume":"5","author":"Lau","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2008.01.038_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","article-title":"Diagnostic strategy for the assessment of rheumatoid vasculitis","volume":"62","author":"Voskuyl","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2008.01.038_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10067-006-0338-7","article-title":"Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors","volume":"26","author":"Daza","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib14","first-page":"2597","article-title":"Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis","volume":"28","author":"Wallberg-Jonsson","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0049-3848(89)90317-4","article-title":"Von Willebrand factor is an acute phase reactant in man","volume":"53","author":"Pottinger","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijcard.2008.01.038_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jbspin.2006.01.014","article-title":"Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion","volume":"73","author":"Pham","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ijcard.2008.01.038_bib17","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0038-1650578","article-title":"Elevated circulating P-selectin in insulin dependent diabetes mellitus","volume":"76","author":"Jilma","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2008.01.038_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0021-9150(00)00672-9","article-title":"Soluble adhesion molecules and unstable coronary artery disease","volume":"156","author":"Parker","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2008.01.038_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20030172","article-title":"Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection","volume":"105","author":"Chin","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ijcard.2008.01.038_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","article-title":"A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis","volume":"36","author":"Littler","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib22","first-page":"1054","article-title":"P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis","volume":"25","author":"Ertenli","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/rheumatology\/34.9.814","article-title":"Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis","volume":"34","author":"Blann","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10067-004-0915-6","article-title":"Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level","volume":"23","author":"Cobankara","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijcard.2008.01.038_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.61.3.242","article-title":"Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study","volume":"61","author":"Kuuliala","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2008.01.038_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1055\/s-0038-1648993","article-title":"Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control","volume":"72","author":"Steiner","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2008.01.038_bib27","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.CIR.0000143073.60937.50","article-title":"Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide","volume":"110","author":"Chong","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2008.01.038_bib28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehm102","article-title":"Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5\u00a0year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)","volume":"28","author":"Hobbs","year":"2007","journal-title":"Eur Heart J"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308003458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308003458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:24:30Z","timestamp":1759091070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527308003458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0167527308003458"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.01.038","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma indices of endothelial and platelet activation in Rheumatoid Disease: Relationship to cardiovascular co-morbidity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}